Bioinformatics Vol. 16 no. 4 2000
Pages 400-401
© 2000 Oxford University Press
Detecting hypermutations in viral sequences with an emphasis on G 
A hypermutation
1 Theoretical Biology and Biophysics, Los Alamos National Laboratories, MS K710 Los Alamos, NM 87544, USA
Received on October 25, 1999
; revised on November 30, 1999
; accepted on December 7, 1999
Summary: This program compares sequence sets to a reference
sequence, tallies G 
A hypermutations, and presents the results
in various tables and graphs, which include dinucleotide context,
summaries of all observed nucleotide changes, and stop codons
introduced by hypermutation.
Availability: www.hiv.lanl.gov/HYPERMUT/hypermut.html
Contact: pxr{at}t10.lanl.govor btk{at}t10.lanl.gov
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. A. Knoepfel, N. C. Salisch, P. M. Huelsmann, P. Rauch, H. Walter, and K. J. Metzner Comparison of G-to-A Mutation Frequencies Induced by APOBEC3 Proteins in H9 Cells and Peripheral Blood Mononuclear Cells in the Context of Impaired Processivities of Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Variants J. Virol., July 1, 2008; 82(13): 6536 - 6545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. F. Mulder, A. Harari, and V. Simon Cytidine deamination induced HIV-1 drug resistance PNAS, April 8, 2008; 105(14): 5501 - 5506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Aguiar, N. Lovsin, A. Tanuri, and B. M. Peterlin Vpr.A3A Chimera Inhibits HIV Replication J. Biol. Chem., February 1, 2008; 283(5): 2518 - 2525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Luo, T. Wang, B. Liu, C. Tian, Z. Xiao, J. Kappes, and X.-F. Yu Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation J. Virol., July 1, 2007; 81(13): 7238 - 7248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Rousseau, G. H. Learn, T. Bhattacharya, D. C. Nickle, D. Heckerman, S. Chetty, C. Brander, P. J. R. Goulder, B. D. Walker, P. Kiepiela, et al. Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections J. Virol., May 1, 2007; 81(9): 4492 - 4500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pace, J. Keller, D. Nolan, I. James, S. Gaudieri, C. Moore, and S. Mallal Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation. J. Virol., September 1, 2006; 80(18): 9259 - 9269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. W. Frost, T. Wrin, D. M. Smith, S. L. K. Pond, Y. Liu, E. Paxinos, C. Chappey, J. Galovich, J. Beauchaine, C. J. Petropoulos, et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection PNAS, December 20, 2005; 102(51): 18514 - 18519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. O. Yang, J. Church, C. M. R. Kitchen, R. Kilpatrick, A. Ali, Y. Geng, M. S. Killian, R. L. Sabado, H. Ng, J. Suen, et al. Genetic and Stochastic Influences on the Interaction of Human Immunodeficiency Virus Type 1 and Cytotoxic T Lymphocytes in Identical Twins J. Virol., December 15, 2005; 79(24): 15368 - 15375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lemey, I. Derdelinckx, A. Rambaut, K. Van Laethem, S. Dumont, S. Vermeulen, E. Van Wijngaerden, and A.-M. Vandamme Molecular Footprint of Drug-Selective Pressure in a Human Immunodeficiency Virus Transmission Chain J. Virol., September 15, 2005; 79(18): 11981 - 11989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Tobin, G. H. Learn, S. E. Holte, Y. Wang, A. J. Melvin, J. L. McKernan, D. M. Pawluk, K. M. Mohan, P. F. Lewis, J. I. Mullins, et al. Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus J. Virol., August 1, 2005; 79(15): 9625 - 9634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Kieffer, P. Kwon, R. E. Nettles, Y. Han, S. C. Ray, and R. F. Siliciano G->A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo J. Virol., February 1, 2005; 79(3): 1975 - 1980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N. R. Landau APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication J. Biol. Chem., December 17, 2004; 279(51): 53379 - 53386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Kuhmann, P. Pugach, K. J. Kunstman, J. Taylor, R. L. Stanfield, A. Snyder, J. M. Strizki, J. Riley, B. M. Baroudy, I. A. Wilson, et al. Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor J. Virol., March 15, 2004; 78(6): 2790 - 2807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Robbins, P. Lemey, O. G. Pybus, H. W. Jaffe, A. S. Youngpairoj, T. M. Brown, M. Salemi, A.-M. Vandamme, and M. L. Kalish U.S. Human Immunodeficiency Virus Type 1 Epidemic: Date of Origin, Population History, and Characterization of Early Strains J. Virol., June 1, 2003; 77(11): 6359 - 6366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Janini, M. Rogers, D. R. Birx, and F. E. McCutchan Human Immunodeficiency Virus Type 1 DNA Sequences Genetically Damaged by Hypermutation Are Often Abundant in Patient Peripheral Blood Mononuclear Cells and May Be Generated during Near-Simultaneous Infection and Activation of CD4+ T Cells J. Virol., September 1, 2001; 75(17): 7973 - 7986. [Abstract] [Full Text] [PDF]
|
|